Gilead Sciences, Inc.
GILD
$113.99
-$0.44-0.39%
| Weiss Ratings | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | B | |||
| Rating Factors | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Fair | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.25 | |||
| Price History | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.72% | |||
| 30-Day Total Return | 21.46% | |||
| 60-Day Total Return | 24.43% | |||
| 90-Day Total Return | 30.50% | |||
| Year to Date Total Return | 24.06% | |||
| 1-Year Total Return | 58.04% | |||
| 2-Year Total Return | 54.99% | |||
| 3-Year Total Return | 118.81% | |||
| 5-Year Total Return | 101.99% | |||
| 52-Week High % Change | -4.61% | |||
| 52-Week Low % Change | 84.36% | |||
| Price | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $119.96 | |||
| 52-Week Low Price | $62.07 | |||
| 52-Week Low Price (Date) | May 31, 2024 | |||
| 52-Week High Price (Date) | Mar 10, 2025 | |||
| Valuation | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 142.50B | |||
| Enterprise Value | 158.17B | |||
| Price/Earnings (TTM) | 322.43 | |||
| Earnings Per Share (TTM) | 0.35 | |||
| Earnings Per Share Growth | -92.09% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 5.01 | |||
| Price/Book (Q) | 7.38 | |||
| Enterprise Value/Revenue (TTM) | 5.50 | |||
| Price | $113.99 | |||
| Enterprise Value/EBITDA (TTM) | 11.78 | |||
| Enterprise Value/EBIT | 14.83 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.26B | |||
| Dividend Yield | 2.69% | |||
| Div. Per Share (Most Recent) | $0.77 | |||
| Dividend Per Share (TTM) | $3.08 | |||
| Payout Ratio (TTM) | 816.25% | |||
| Dividend Per Share (Most Recent) | $0.77 | |||
| Company Info | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 574 3000 | |||
| Address | 333 Lakeside Drive Foster City, CA 94404 | |||
| Website | www.gilead.com | |||
| Country | United States | |||
| Year Founded | 1987 | |||
| Profitability | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 37.08% | |||
| Profit Margin | 1.66% | |||
| Management Effectiveness | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 11.00% | |||
| Return on Equity | 2.29% | |||
| Income Statement | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 28.75B | |||
| Total Revenue (TTM) | 28.75B | |||
| Revenue Per Share | $22.84 | |||
| Gross Profit (TTM) | 22.50B | |||
| EBITDA (TTM) | 13.43B | |||
| EBIT (TTM) | 10.66B | |||
| Net Income (TTM) | 480.00M | |||
| Net Income Avl. to Common (TTM) | 480.00M | |||
| Total Revenue Growth (Q YOY) | 6.40% | |||
| Earnings Growth (Q YOY) | 25.83% | |||
| EPS Diluted (TTM) | 0.35 | |||
| EPS Diluted Growth (Q YOY) | 24.78% | |||
| Balance Sheet | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.57B | |||
| Cash Per Share (Q) | $9.19 | |||
| Total Current Assets (Q) | 19.17B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 19.25B | |||
| Current Ratio (Q) | 1.597 | |||
| Book Value Per Share (Q) | $15.51 | |||
| Total Assets (Q) | 59.00B | |||
| Total Current Liabilities (Q) | 12.00B | |||
| Total Debt (Q) | 27.32B | |||
| Total Liabilities (Q) | 39.75B | |||
| Total Common Equity (Q) | 19.33B | |||
| Cash Flow | GILD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -3.45B | |||
| Cash from Financing (TTM) | -3.43B | |||
| Net Change in Cash (TTM) | 3.91B | |||
| Levered Free Cash Flow (TTM) | 9.82B | |||
| Cash from Operations (TTM) | 10.83B | |||
